SCHEMBL13298591

SCHEMBL13298591

c1ccc([SiH2]c2ccc3c(-c4cccc5ccccc45)c4ccccc4c(-c4cc(-c5ccc6ccccc6c5)cc(-c5ccc6ccccc6c5)c4)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 2/20 0.35
▸ SOS1 Q07889 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.33
▸ HSD17B1 P14061 2/20 0.33
▸ HSD17B2 P37059 2/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC8 Q9BY41 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MCL1 Q07820 1/20 0.32
▸ ACMSD Q8TDX5 1/20 0.32
▸ CA12 O43570 3/20 0.32
▸ CA1 P00915 3/20 0.32
▸ CA2 P00918 3/20 0.32
▸ CA9 Q16790 3/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ GSTP1 P09211 1/20 0.31
▸ ESR1 P03372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298584 1.00 PIM1 (0.35) PIM1SOS1GPR84HSD17B1HSD17B2
SCHEMBL13298555 0.95 HSD17B1 (0.35) PIM1SOS1GPR84HSD17B1HSD17B2
SCHEMBL13298549 0.95 HSD17B1 (0.35) PIM1SOS1GPR84HSD17B1HSD17B2
SCHEMBL13298516 0.94 PIM1 (0.36) PIM1SOS1GPR84HSD17B1HSD17B2
SCHEMBL13298511 0.94 PIM1 (0.36) PIM1SOS1GPR84HSD17B1HSD17B2
SCHEMBL13298582 0.92 PIM1 (0.36) PIM1SOS1GPR84HDAC4HDAC2
SCHEMBL13298587 0.92 PIM1 (0.36) PIM1SOS1GPR84HDAC4HDAC2
SCHEMBL13298569 0.90 CA12 (0.34) SOS1ALDH1A1MAPTMCL1ACMSD
SCHEMBL13298573 0.90 CA12 (0.34) SOS1ALDH1A1MAPTMCL1ACMSD
SCHEMBL13298590 0.90 ESR1 (0.36) GPR84HSD17B1HSD17B2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 PIM1 3565/4885SOS1 2366/4885GPR84 1959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback